Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis
Endocrine Reviews · 2025
DOI: 10.1210/endrev/bnaf039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, 2025. Verfasst von Yun Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Placenta, Placental Hormones, Gonadal Steroid Hormones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The human placenta serves as the predominant endocrine organ throughout pregnancy, assuming a central role in preserving endocrine homeostasis, facilitating maternal physiological adaptation, and safeguarding fetal well-being. Preeclampsia (PE), a multifaceted and systemic gestational complication, stands as a primary contributor to maternal and perinatal morbidity and mortality. Defective placental development has been extensively acknowledged as the fundamental pathological foundation underlying this condition. Accumulating evidence has unveiled a disruption in the balance of steroid hormone production within placentas affected by early-onset PE (E-PE). Considerable endeavors have been undertaken to decipher the endocrine mechanisms driving E-PE. Recent investigations have illuminated a complex, multitiered regulatory system that governs placental steroidogenesis, encompassing epigenetic controls such as microRNA activity and metabolic flux-conjugated histone acetylation, posttranslational modifications including O-linked β-N-acetylglucosamine, as well as intricate endocrine feedback loops among steroids and other signaling molecules like melatonin. Notably, a growing body of evidence robustly supports a causal link between elevated placental testosterone synthesis and the onset of PE. Nevertheless, comprehensive studies exploring the endocrine pathophysiology of PE remain essential to illuminate novel therapeutic avenues for mitigating this adverse pregnancy outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 101408, China.
- Beijing Institute of Stem Cell and Regenerative Medicine, Beijing 100101, China.
ORCID-Profile: Yun Yang, Shanshan Zhang, Xiao Fang, Tengqi Shao, Xuan Shao, Yan-Ling Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y., Zhang, S., Fang, X., Shao, T., Shao, X., & Wang, Y. L. (2025). Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis. Endocrine Reviews. https://doi.org/10.1210/endrev/bnaf039
Vancouver
Yang Y, Zhang S, Fang X, Shao T, Shao X, Wang YL. Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis. Endocrine Reviews. 2025. doi:10.1210/endrev/bnaf039
BibTeX
@article{Yang2025,
author = {Yang, Yun and Zhang, Shanshan and Fang, Xiao and Shao, Tengqi and Shao, Xuan and Wang, Yan-Ling},
title = {Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis},
journal = {Endocrine Reviews},
year = {2025},
doi = {10.1210/endrev/bnaf039}
}
EUVIMED